Skip to main content
Top
Published in: Rheumatology International 4/2013

01-04-2013 | Original Article

Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents

Authors: Tomoko Otake, Mutsumi Ashihara, Jo Nishino, Kenichi Kato, Shusaku Fukaya, Shunji Yoshida

Published in: Rheumatology International | Issue 4/2013

Login to get access

Abstract

The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, “What do you feel is your strongest stressor?” The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.
Literature
1.
go back to reference Alexander F (1950) Psychosomaic Medicine. WW. Norton and Company, New York, pp 104–106 Alexander F (1950) Psychosomaic Medicine. WW. Norton and Company, New York, pp 104–106
2.
3.
go back to reference Suurmeijer TP, Waltz T et al (2001) Quality of life profiles in the first year of rheumatoid arthritis. Arthritis Rheum 45:111–121PubMedCrossRef Suurmeijer TP, Waltz T et al (2001) Quality of life profiles in the first year of rheumatoid arthritis. Arthritis Rheum 45:111–121PubMedCrossRef
4.
go back to reference Stojanovich L, Marisavljevich D et al (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213PubMedCrossRef Stojanovich L, Marisavljevich D et al (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213PubMedCrossRef
5.
go back to reference Mahat G (1997) Perceived stressor and coping strategies among individuals with rheumatoid arthritis. J Adv Nurs 25:1144–1150PubMedCrossRef Mahat G (1997) Perceived stressor and coping strategies among individuals with rheumatoid arthritis. J Adv Nurs 25:1144–1150PubMedCrossRef
6.
go back to reference Meenan RF, Gertman PM et al (1980) Measuring health status in arthritis: the arthritis impact measurement scales. Arthritis Rheum 23:146–152PubMedCrossRef Meenan RF, Gertman PM et al (1980) Measuring health status in arthritis: the arthritis impact measurement scales. Arthritis Rheum 23:146–152PubMedCrossRef
7.
go back to reference Meenan RF, Mason JH et al (1992) AIMS2: the content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum 35:1–10PubMedCrossRef Meenan RF, Mason JH et al (1992) AIMS2: the content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum 35:1–10PubMedCrossRef
8.
go back to reference American Psychiatric Association (1980) Quick reference to the diagnostic criteria from DSM-III. American Psychiatric Publishing, Washington, DC American Psychiatric Association (1980) Quick reference to the diagnostic criteria from DSM-III. American Psychiatric Publishing, Washington, DC
9.
go back to reference American Psychiatric Association (1994) Quick reference to the diagnostic criteria from DSM-IV. American Psychiatric Publishing, Washington, DC American Psychiatric Association (1994) Quick reference to the diagnostic criteria from DSM-IV. American Psychiatric Publishing, Washington, DC
10.
go back to reference Prevoo ML, Van t Hof MA et al (1995) Modified disease activity score that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, Van t Hof MA et al (1995) Modified disease activity score that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
11.
go back to reference Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto
13.
go back to reference Van Lankveld W, Naring G et al (1993) Stress caused by rheumatoid arthritis: relation among subjective stressor of the disease, disease status and well-being. J Behav Med 16:309–321PubMedCrossRef Van Lankveld W, Naring G et al (1993) Stress caused by rheumatoid arthritis: relation among subjective stressor of the disease, disease status and well-being. J Behav Med 16:309–321PubMedCrossRef
14.
go back to reference Maini RN, Breedveld FC et al (2004) Sustained improvement over 2 years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50:1051–1065PubMedCrossRef Maini RN, Breedveld FC et al (2004) Sustained improvement over 2 years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50:1051–1065PubMedCrossRef
15.
go back to reference Goekoop-Ruiterman YPM, De Vries-Bouwstra JK et al (2005) Clinical and radiographic outcome of four different treatment strategies in patients with early rheumatoid arthritis (the Best study). Arthritis Rheum 52:3381–3390PubMedCrossRef Goekoop-Ruiterman YPM, De Vries-Bouwstra JK et al (2005) Clinical and radiographic outcome of four different treatment strategies in patients with early rheumatoid arthritis (the Best study). Arthritis Rheum 52:3381–3390PubMedCrossRef
16.
go back to reference Yocum D, Rahman MV et al (2004) Infliximab rapidly improves all components of physical function assessed by the HAQ in patients with rheumatoid arthritis. Arthritis Rheum 50:118–122CrossRef Yocum D, Rahman MV et al (2004) Infliximab rapidly improves all components of physical function assessed by the HAQ in patients with rheumatoid arthritis. Arthritis Rheum 50:118–122CrossRef
17.
go back to reference Russell AS (2008) Quality-of-life assessment in rheumatoid arthritis. Pharmacoeconomics 26:831–846PubMedCrossRef Russell AS (2008) Quality-of-life assessment in rheumatoid arthritis. Pharmacoeconomics 26:831–846PubMedCrossRef
18.
go back to reference Odegard S, Finset A et al (2007) Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 66:1195–1201PubMedCrossRef Odegard S, Finset A et al (2007) Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 66:1195–1201PubMedCrossRef
19.
go back to reference Zeitlin DJ (1977) Psychological issues in the management of rheumatoid arthritis. Psychosomatics 18:7–14PubMed Zeitlin DJ (1977) Psychological issues in the management of rheumatoid arthritis. Psychosomatics 18:7–14PubMed
Metadata
Title
Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents
Authors
Tomoko Otake
Mutsumi Ashihara
Jo Nishino
Kenichi Kato
Shusaku Fukaya
Shunji Yoshida
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2457-6

Other articles of this Issue 4/2013

Rheumatology International 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.